// =============================================================================
// SOMA Neurologia Detallada Enciclopedia — Spanish-First Bilingual
// Detailed Neurology Patient Education Content
// =============================================================================
// ARCHITECTURE: JSON.parse() wrapper prevents TS2590 "expression too complex"
// =============================================================================

export interface NeurologiaEntry {
  id: string;
  nombreEs: string;
  nombreEn: string;
  categoriaEs: string;
  categoriaEn: string;
  descripcionEs: string;
  descripcionEn: string;
  sintomasEs: string[];
  sintomasEn: string[];
  factoresRiesgoEs: string[];
  factoresRiesgoEn: string[];
  diagnosticoEs: string[];
  diagnosticoEn: string[];
  tratamientoEs: string[];
  tratamientoEn: string[];
  prevencionEs: string[];
  prevencionEn: string[];
  cuandoIrAUrgenciasEs: string[];
  cuandoIrAUrgenciasEn: string[];
  datosClaveEs: string[];
  datosClaveEn: string[];
}

export const neurologiaEnciclopedia: NeurologiaEntry[] = JSON.parse(`[
  {"id":"neuro-acv","nombreEs":"Accidente Cerebrovascular (ACV/Ictus)","nombreEn":"Stroke (CVA)","categoriaEs":"Cerebrovascular","categoriaEn":"Cerebrovascular","descripcionEs":"Interrupcion del flujo sanguineo cerebral que causa muerte del tejido nervioso. Puede ser isquemico (coagulo, 87%) o hemorragico (sangrado, 13%). Es una emergencia donde cada minuto que pasa mueren 1.9 millones de neuronas.","descripcionEn":"Interruption of cerebral blood flow causing nerve tissue death. Can be ischemic (clot, 87%) or hemorrhagic (bleeding, 13%). An emergency where 1.9 million neurons die every minute that passes.","sintomasEs":["Regla RAPIDO: Rostro caido, Arm (brazo) debil, Palabra dificultosa, Inmediatamente llame al 911, Diga la hora de inicio, Observe todos los sintomas","Debilidad o adormecimiento subito de cara, brazo o pierna (un lado)","Confusion o dificultad para hablar/entender","Perdida subita de vision en uno o ambos ojos","Mareo severo, perdida de equilibrio o coordinacion","Dolor de cabeza severo e inusual (hemorragico)"],"sintomasEn":["FAST rule: Face drooping, Arm weakness, Speech difficulty, Time to call 911","Sudden weakness or numbness of face, arm, or leg (one side)","Confusion or difficulty speaking/understanding","Sudden vision loss in one or both eyes","Severe dizziness, loss of balance or coordination","Severe unusual headache (hemorrhagic)"],"factoresRiesgoEs":["Hipertension (factor principal)","Fibrilacion auricular","Diabetes","Tabaquismo","Colesterol alto","Obesidad","ACV previo o AIT","Enfermedad carotidea"],"factoresRiesgoEn":["Hypertension (main factor)","Atrial fibrillation","Diabetes","Smoking","High cholesterol","Obesity","Prior stroke or TIA","Carotid disease"],"diagnosticoEs":["TAC cerebral urgente (descarta hemorragia en minutos)","RM cerebral (mas sensible para ACV isquemico)","Angio-TAC o angio-RM (ver vasos cerebrales)","ECG y monitoreo cardiaco (buscar FA)","Ultrasonido carotideo","Laboratorios: glucosa, coagulacion, hemograma"],"diagnosticoEn":["Urgent brain CT (rules out hemorrhage in minutes)","Brain MRI (more sensitive for ischemic stroke)","CT angiography or MR angiography (view cerebral vessels)","ECG and cardiac monitoring (look for AF)","Carotid ultrasound","Labs: glucose, coagulation, CBC"],"tratamientoEs":["ACV isquemico: trombolisis IV (alteplasa) dentro de 4.5 horas","Trombectomia mecanica hasta 24 horas en casos seleccionados","Control de presion arterial","Antiagregacion plaquetaria post-ACV isquemico","Anticoagulacion si FA","Rehabilitacion: fisioterapia, terapia ocupacional, terapia de lenguaje","Prevencion secundaria agresiva"],"tratamientoEn":["Ischemic stroke: IV thrombolysis (alteplase) within 4.5 hours","Mechanical thrombectomy up to 24 hours in selected cases","Blood pressure control","Antiplatelet therapy post-ischemic stroke","Anticoagulation if AF","Rehabilitation: physical therapy, occupational therapy, speech therapy","Aggressive secondary prevention"],"prevencionEs":["Control de presion arterial (<130/80)","Anticoagulacion si hay FA","No fumar","Ejercicio regular","Dieta saludable","Control de diabetes y colesterol","Reconocer y tratar AIT (mini-stroke) urgentemente"],"prevencionEn":["Blood pressure control (<130/80)","Anticoagulation if AF present","No smoking","Regular exercise","Healthy diet","Diabetes and cholesterol control","Recognize and urgently treat TIA (mini-stroke)"],"cuandoIrAUrgenciasEs":["SIEMPRE — cualquier sintoma neurologico subito","Rostro caido de un lado","Debilidad de brazo o pierna","Dificultad para hablar","Perdida de vision subita","NO esperar — el tratamiento es tiempo-dependiente"],"cuandoIrAUrgenciasEn":["ALWAYS — any sudden neurological symptom","Face drooping on one side","Arm or leg weakness","Difficulty speaking","Sudden vision loss","Do NOT wait — treatment is time-dependent"],"datosClaveEs":["2da causa de muerte y 1ra de discapacidad mundial","La trombolisis reduce discapacidad si se da en las primeras 4.5 horas","Cada minuto de retraso se pierden 1.9 millones de neuronas","El AIT (mini-stroke) es una advertencia urgente — 10-15% tienen ACV en 90 dias","La rehabilitacion temprana mejora significativamente la recuperacion"],"datosClaveEn":["2nd cause of death and 1st of disability worldwide","Thrombolysis reduces disability if given within first 4.5 hours","Every minute of delay loses 1.9 million neurons","TIA (mini-stroke) is an urgent warning — 10-15% have stroke within 90 days","Early rehabilitation significantly improves recovery"]},
  {"id":"neuro-epilepsia","nombreEs":"Epilepsia","nombreEn":"Epilepsy","categoriaEs":"Convulsiva","categoriaEn":"Seizure","descripcionEs":"Trastorno neurologico cronico caracterizado por convulsiones recurrentes no provocadas. Afecta a 50 millones de personas mundialmente. Con tratamiento adecuado, el 70% de pacientes logra control de las crisis.","descripcionEn":"Chronic neurological disorder characterized by recurrent unprovoked seizures. Affects 50 million people worldwide. With adequate treatment, 70% of patients achieve seizure control.","sintomasEs":["Crisis tonico-clonicas: rigidez y sacudidas de todo el cuerpo, perdida de conciencia","Crisis de ausencia: mirada fija momentanea, parpadeo (comun en ninos)","Crisis focales: movimientos o sensaciones en una parte del cuerpo","Aura: sensacion previa (dejavu, olor, sabor)","Confusion postictal despues de la crisis","Mordedura de lengua e incontinencia (en tonico-clonicas)"],"sintomasEn":["Tonic-clonic seizures: stiffness and shaking of whole body, loss of consciousness","Absence seizures: momentary blank stare, blinking (common in children)","Focal seizures: movements or sensations in one body part","Aura: preceding sensation (dejavu, smell, taste)","Postictal confusion after seizure","Tongue biting and incontinence (in tonic-clonic)"],"factoresRiesgoEs":["Antecedente familiar de epilepsia","Lesion cerebral traumatica","ACV","Infecciones del SNC (meningitis, encefalitis)","Tumores cerebrales","Malformaciones del desarrollo cerebral","Convulsiones febriles prolongadas en la infancia"],"factoresRiesgoEn":["Family history of epilepsy","Traumatic brain injury","Stroke","CNS infections (meningitis, encephalitis)","Brain tumors","Brain developmental malformations","Prolonged febrile seizures in childhood"],"diagnosticoEs":["Electroencefalograma (EEG) — estandar","Resonancia magnetica cerebral","Video-EEG prolongado (en epilepsia refractaria)","Pruebas neuropsicologicas","Laboratorios: glucosa, electrolitos, toxicologia","Historia detallada del evento por testigos"],"diagnosticoEn":["Electroencephalogram (EEG) — standard","Brain MRI","Prolonged video-EEG (in refractory epilepsy)","Neuropsychological testing","Labs: glucose, electrolytes, toxicology","Detailed event history from witnesses"],"tratamientoEs":["Anticonvulsivantes: levetiracetam, lamotrigina, valproato, carbamazepina","Monoterapia es la meta inicial","60-70% se controlan con primer o segundo medicamento","Cirugia de epilepsia en casos refractarios con foco identificable","Estimulador del nervio vago (VNS)","Dieta cetogenica (especialmente en ninos refractarios)","Nunca suspender medicamento abruptamente"],"tratamientoEn":["Anticonvulsants: levetiracetam, lamotrigine, valproate, carbamazepine","Monotherapy is the initial goal","60-70% controlled with first or second medication","Epilepsy surgery in refractory cases with identifiable focus","Vagus nerve stimulator (VNS)","Ketogenic diet (especially in refractory children)","Never abruptly stop medication"],"prevencionEs":["Uso de casco en actividades de riesgo","Cinturon de seguridad siempre","Tratar infecciones del SNC promptamente","Control de factores de riesgo para ACV","Sueno adecuado (la privacion de sueno desencadena crisis)","Evitar alcohol excesivo"],"prevencionEn":["Helmet use in risky activities","Always wear seatbelt","Promptly treat CNS infections","Stroke risk factor control","Adequate sleep (sleep deprivation triggers seizures)","Avoid excessive alcohol"],"cuandoIrAUrgenciasEs":["Primera convulsion en la vida","Convulsion que dura mas de 5 minutos (status epileptico)","Convulsiones repetidas sin recuperacion entre ellas","No recupera conciencia despues de 10 minutos","Convulsion en embarazada","Lesion durante la convulsion","Convulsion en agua"],"cuandoIrAUrgenciasEn":["First seizure in life","Seizure lasting more than 5 minutes (status epilepticus)","Repeated seizures without recovery between them","Does not regain consciousness after 10 minutes","Seizure in pregnant woman","Injury during seizure","Seizure in water"],"datosClaveEs":["50 millones de personas tienen epilepsia mundialmente","70% se controlan con medicamentos","La epilepsia NO es contagiosa ni un trastorno mental","Nunca meter objetos en la boca durante una convulsion","Personas con epilepsia controlada pueden llevar vida completamente normal","El estigma sigue siendo un problema mayor que la enfermedad en muchos paises"],"datosClaveEn":["50 million people have epilepsy worldwide","70% are controlled with medications","Epilepsy is NOT contagious nor a mental disorder","Never put objects in the mouth during a seizure","People with controlled epilepsy can lead completely normal lives","Stigma remains a bigger problem than the disease in many countries"]},
  {"id":"neuro-migrana","nombreEs":"Migrana","nombreEn":"Migraine","categoriaEs":"Cefalea","categoriaEn":"Headache","descripcionEs":"Trastorno neurologico primario que causa dolor de cabeza intenso recurrente, frecuentemente con nausea, vomito y sensibilidad a luz y sonido. Afecta al 12% de la poblacion. Es 3 veces mas comun en mujeres.","descripcionEn":"Primary neurological disorder causing recurrent intense headache, frequently with nausea, vomiting, and light and sound sensitivity. Affects 12% of population. 3 times more common in women.","sintomasEs":["Dolor pulsatil, tipicamente unilateral","Nausea y/o vomito","Fotofobia (sensibilidad a la luz)","Fonofobia (sensibilidad al sonido)","Aura visual (20-30%): destellos, lineas en zigzag, puntos ciegos","Empeora con actividad fisica","Duracion: 4-72 horas sin tratamiento","Prodromos: irritabilidad, bostezos, antojos, horas antes"],"sintomasEn":["Pulsating pain, typically unilateral","Nausea and/or vomiting","Photophobia (light sensitivity)","Phonophobia (sound sensitivity)","Visual aura (20-30%): flashes, zigzag lines, blind spots","Worsens with physical activity","Duration: 4-72 hours without treatment","Prodrome: irritability, yawning, cravings, hours before"],"factoresRiesgoEs":["Sexo femenino (3:1)","Historia familiar fuerte","Estres","Cambios hormonales (menstruacion, anticonceptivos)","Privacion de sueno","Ciertos alimentos (vino tinto, quesos, chocolate, glutamato)","Cambios de clima","Exceso o abstinencia de cafeina"],"factoresRiesgoEn":["Female sex (3:1)","Strong family history","Stress","Hormonal changes (menstruation, contraceptives)","Sleep deprivation","Certain foods (red wine, cheese, chocolate, MSG)","Weather changes","Caffeine excess or withdrawal"],"diagnosticoEs":["Diagnostico clinico basado en criterios ICHD-3","No se necesitan imagenes si la historia es tipica","RM cerebral si: primera migrana despues de los 50, cambio de patron, aura atipica","Diario de cefalea para identificar desencadenantes","Descartar cefaleas secundarias peligrosas"],"diagnosticoEn":["Clinical diagnosis based on ICHD-3 criteria","No imaging needed if history is typical","Brain MRI if: first migraine after 50, pattern change, atypical aura","Headache diary to identify triggers","Rule out dangerous secondary headaches"],"tratamientoEs":["Agudo: triptanes (sumatriptan) — tratamiento de primera linea","Agudo: AINEs (ibuprofeno, naproxeno) para ataques leves-moderados","Agudo: antiemeticos (metoclopramida) para nausea","Preventivo: betabloqueadores, topiramato, amitriptilina, valproato","Preventivo: anticuerpos anti-CGRP (erenumab, fremanezumab) — nuevos y efectivos","Toxina botulinica (Botox) para migrana cronica","Neuromodulacion no invasiva"],"tratamientoEn":["Acute: triptans (sumatriptan) — first-line treatment","Acute: NSAIDs (ibuprofen, naproxen) for mild-moderate attacks","Acute: antiemetics (metoclopramide) for nausea","Preventive: beta-blockers, topiramate, amitriptyline, valproate","Preventive: anti-CGRP antibodies (erenumab, fremanezumab) — new and effective","Botulinum toxin (Botox) for chronic migraine","Non-invasive neuromodulation"],"prevencionEs":["Identificar y evitar desencadenantes personales","Sueno regular (misma hora de acostarse/levantarse)","Ejercicio aerobico regular","Hidratacion adecuada","Manejo del estres (mindfulness, yoga)","No saltar comidas","Medicacion preventiva si 4+ ataques/mes"],"prevencionEn":["Identify and avoid personal triggers","Regular sleep (same bedtime/wake time)","Regular aerobic exercise","Adequate hydration","Stress management (mindfulness, yoga)","Do not skip meals","Preventive medication if 4+ attacks/month"],"cuandoIrAUrgenciasEs":["Dolor de cabeza el peor de su vida (subito, explosivo)","Cefalea con fiebre y rigidez de cuello","Cefalea con confusion o alteracion de conciencia","Primera cefalea despues de los 50 anos","Cefalea con deficit neurologico nuevo","Cefalea post-traumatica severa"],"cuandoIrAUrgenciasEn":["Worst headache of your life (sudden, explosive)","Headache with fever and neck stiffness","Headache with confusion or altered consciousness","First headache after age 50","Headache with new neurological deficit","Severe post-traumatic headache"],"datosClaveEs":["Es la 2da causa de discapacidad mundial (WHO)","No es solo un dolor de cabeza — es un trastorno neurologico","El uso excesivo de analgesicos (>10-15 dias/mes) causa cefalea de rebote","Los triptanes son mas efectivos si se toman temprano en el ataque","Los anti-CGRP son la primera terapia preventiva especifica para migrana","La migrana con aura aumenta ligeramente el riesgo de ACV en mujeres jovenes"],"datosClaveEn":["2nd cause of disability worldwide (WHO)","Not just a headache — it is a neurological disorder","Excessive analgesic use (>10-15 days/month) causes rebound headache","Triptans are more effective if taken early in attack","Anti-CGRPs are the first migraine-specific preventive therapy","Migraine with aura slightly increases stroke risk in young women"]},
  {"id":"neuro-parkinson","nombreEs":"Enfermedad de Parkinson","nombreEn":"Parkinson's Disease","categoriaEs":"Neurodegenerativa","categoriaEn":"Neurodegenerative","descripcionEs":"Enfermedad neurodegenerativa progresiva causada por la perdida de neuronas dopaminergicas en la sustancia negra. Causa sintomas motores (temblor, rigidez, lentitud) y no motores (depresion, estrenimiento, trastornos del sueno).","descripcionEn":"Progressive neurodegenerative disease caused by loss of dopaminergic neurons in the substantia nigra. Causes motor symptoms (tremor, rigidity, slowness) and non-motor symptoms (depression, constipation, sleep disorders).","sintomasEs":["Temblor en reposo (tipicamente comienza en una mano, como contar monedas)","Rigidez muscular (en rueda dentada)","Bradicinesia (lentitud de movimientos)","Inestabilidad postural (en etapas mas avanzadas)","Micrografia (letra pequena)","Hipomimia (cara de mascara, menos expresion)","Voz baja y monotona","No motores: depresion, estrenimiento, perdida de olfato, trastorno de sueno REM"],"sintomasEn":["Resting tremor (typically starts in one hand, pill-rolling)","Muscle rigidity (cogwheel rigidity)","Bradykinesia (slowness of movement)","Postural instability (in more advanced stages)","Micrographia (small handwriting)","Hypomimia (masked face, less expression)","Soft, monotone voice","Non-motor: depression, constipation, loss of smell, REM sleep disorder"],"factoresRiesgoEs":["Edad (incidencia aumenta con la edad)","Sexo masculino (1.5 veces mas comun)","Historia familiar","Exposicion a pesticidas y herbicidas","Traumatismo craneal repetido","Factor protector: cafeina, tabaco (paradojicamente)"],"factoresRiesgoEn":["Age (incidence increases with age)","Male sex (1.5 times more common)","Family history","Pesticide and herbicide exposure","Repeated head trauma","Protective factor: caffeine, tobacco (paradoxically)"],"diagnosticoEs":["Diagnostico clinico (bradicinesia + temblor o rigidez)","Respuesta a levodopa apoya el diagnostico","RM cerebral (para descartar otras causas)","DaTSCAN (imagen de transportador de dopamina)","No hay prueba definitiva — el diagnostico es clinico","Evaluacion por neurologo especializado"],"diagnosticoEn":["Clinical diagnosis (bradykinesia + tremor or rigidity)","Response to levodopa supports diagnosis","Brain MRI (to rule out other causes)","DaTSCAN (dopamine transporter imaging)","No definitive test — diagnosis is clinical","Evaluation by specialized neurologist"],"tratamientoEs":["Levodopa/carbidopa: tratamiento mas efectivo (piedra angular)","Agonistas dopaminergicos: pramipexol, ropinirol","Inhibidores MAO-B: rasagilina, safinamida","Inhibidores COMT: entacapona","Estimulacion cerebral profunda (DBS) en casos avanzados","Ejercicio: fundamental (tai chi, boxeo, baile)","Terapia ocupacional y del habla","Tratamiento de sintomas no motores"],"tratamientoEn":["Levodopa/carbidopa: most effective treatment (cornerstone)","Dopamine agonists: pramipexole, ropinirole","MAO-B inhibitors: rasagiline, safinamide","COMT inhibitors: entacapone","Deep brain stimulation (DBS) in advanced cases","Exercise: fundamental (tai chi, boxing, dance)","Occupational and speech therapy","Non-motor symptom treatment"],"prevencionEs":["No hay prevencion conocida definitiva","Ejercicio regular puede ser neuroprotector","Dieta mediterranea","Consumo moderado de cafe","Evitar exposicion a pesticidas","Proteccion craneal en deportes de contacto"],"prevencionEn":["No definitive known prevention","Regular exercise may be neuroprotective","Mediterranean diet","Moderate coffee consumption","Avoid pesticide exposure","Head protection in contact sports"],"cuandoIrAUrgenciasEs":["Sindrome neuroliptico maligno (rigidez extrema, fiebre alta — emergencia)","Caida con lesion","Psicosis severa (alucinaciones, agitacion)","Disfagia severa con riesgo de aspiracion","No tomar levodopa por error y presentar rigidez severa"],"cuandoIrAUrgenciasEn":["Neuroleptic malignant syndrome (extreme rigidity, high fever — emergency)","Fall with injury","Severe psychosis (hallucinations, agitation)","Severe dysphagia with aspiration risk","Missing levodopa by mistake and experiencing severe rigidity"],"datosClaveEs":["Afecta a 8.5 millones de personas mundialmente","No tiene cura pero el tratamiento mejora enormemente la calidad de vida","El ejercicio es tan importante como la medicacion","Los sintomas no motores pueden preceder a los motores por anos","La levodopa sigue siendo el farmaco mas efectivo 50 anos despues de su descubrimiento","La estimulacion cerebral profunda puede ser transformadora en pacientes seleccionados"],"datosClaveEn":["Affects 8.5 million people worldwide","Has no cure but treatment greatly improves quality of life","Exercise is as important as medication","Non-motor symptoms can precede motor symptoms by years","Levodopa remains the most effective drug 50 years after its discovery","Deep brain stimulation can be transformative in selected patients"]},
  {"id":"neuro-esclerosis-multiple","nombreEs":"Esclerosis Multiple","nombreEn":"Multiple Sclerosis","categoriaEs":"Autoinmune","categoriaEn":"Autoimmune","descripcionEs":"Enfermedad autoinmune cronica del sistema nervioso central donde el sistema inmune ataca la mielina. Causa episodios de disfuncion neurologica (brotes) que pueden afectar cualquier parte del SNC.","descripcionEn":"Chronic autoimmune central nervous system disease where the immune system attacks myelin. Causes episodes of neurological dysfunction (relapses) that can affect any part of the CNS.","sintomasEs":["Neuritis optica: perdida de vision dolorosa en un ojo","Adormecimiento u hormigueo en extremidades","Debilidad en piernas o brazos","Fatiga incapacitante (sintoma mas comun)","Signo de Lhermitte: descarga electrica al flexionar el cuello","Problemas de equilibrio y coordinacion","Disfuncion vesical (urgencia, frecuencia)","Deterioro cognitivo (memoria, concentracion)"],"sintomasEn":["Optic neuritis: painful vision loss in one eye","Numbness or tingling in extremities","Weakness in legs or arms","Incapacitating fatigue (most common symptom)","Lhermitte sign: electric shock sensation when flexing neck","Balance and coordination problems","Bladder dysfunction (urgency, frequency)","Cognitive impairment (memory, concentration)"],"factoresRiesgoEs":["Sexo femenino (2-3 veces mas comun)","Edad 20-40 anos (inicio tipico)","Latitudes altas (alejadas del ecuador)","Deficiencia de vitamina D","Tabaquismo","Infeccion por virus Epstein-Barr","Historia familiar","Obesidad en adolescencia"],"factoresRiesgoEn":["Female sex (2-3 times more common)","Age 20-40 (typical onset)","High latitudes (far from equator)","Vitamin D deficiency","Smoking","Epstein-Barr virus infection","Family history","Adolescent obesity"],"diagnosticoEs":["Criterios de McDonald (diseminacion en tiempo y espacio)","RM cerebral y medular con gadolinio","Bandas oligoclonales en liquido cefalorraquideo","Potenciales evocados visuales","OCT (tomografia de coherencia optica)","Descartar otras causas (neuromielitis optica, sarcoidosis)"],"diagnosticoEn":["McDonald criteria (dissemination in time and space)","Brain and spinal MRI with gadolinium","Oligoclonal bands in cerebrospinal fluid","Visual evoked potentials","OCT (optical coherence tomography)","Rule out other causes (neuromyelitis optica, sarcoidosis)"],"tratamientoEs":["Brotes: metilprednisolona IV por 3-5 dias","Terapias modificadoras de enfermedad (TME): 20+ opciones","TME inyectables: interferones, acetato de glatiramer","TME orales: fingolimod, dimetilfumarato, teriflunomida","TME alta eficacia: natalizumab, ocrelizumab, alemtuzumab","Tratamiento sintomatico: fatiga, espasticidad, dolor, vejiga","Rehabilitacion multidisciplinaria"],"treatmentEn":["Relapses: IV methylprednisolone for 3-5 days","Disease-modifying therapies (DMTs): 20+ options","Injectable DMTs: interferons, glatiramer acetate","Oral DMTs: fingolimod, dimethyl fumarate, teriflunomide","High-efficacy DMTs: natalizumab, ocrelizumab, alemtuzumab","Symptomatic treatment: fatigue, spasticity, pain, bladder","Multidisciplinary rehabilitation"],"tratamientoEn":["Relapses: IV methylprednisolone for 3-5 days","Disease-modifying therapies (DMTs): 20+ options","Injectable DMTs: interferons, glatiramer acetate","Oral DMTs: fingolimod, dimethyl fumarate, teriflunomide","High-efficacy DMTs: natalizumab, ocrelizumab, alemtuzumab","Symptomatic treatment: fatigue, spasticity, pain, bladder","Multidisciplinary rehabilitation"],"prevencionEs":["No hay prevencion conocida","Suplemento de vitamina D puede reducir riesgo","No fumar","Mantener peso saludable en adolescencia","Ejercicio regular mejora sintomas y calidad de vida"],"prevencionEn":["No known prevention","Vitamin D supplementation may reduce risk","No smoking","Maintain healthy weight in adolescence","Regular exercise improves symptoms and quality of life"],"cuandoIrAUrgenciasEs":["Perdida de vision subita","Debilidad severa nueva","Dificultad para caminar aguda","Retencion urinaria","Sintomas nuevos severos que pueden ser un brote"],"cuandoIrAUrgenciasEn":["Sudden vision loss","New severe weakness","Acute difficulty walking","Urinary retention","New severe symptoms that may be a relapse"],"datosClaveEs":["2.8 millones de personas viven con EM mundialmente","El inicio temprano del tratamiento mejora el pronostico","Las terapias de alta eficacia usadas tempranamente tienen mejor resultado","La EM no es una sentencia de discapacidad con tratamiento moderno","El ejercicio es seguro y beneficioso","El embarazo reduce los brotes (las hormonas son protectoras)"],"datosClaveEn":["2.8 million people live with MS worldwide","Early treatment initiation improves prognosis","High-efficacy therapies used early have better outcomes","MS is not a disability sentence with modern treatment","Exercise is safe and beneficial","Pregnancy reduces relapses (hormones are protective)"]}
]`);

// ── Helper functions ────────────────────────────────────────────────

export function buscarNeurologia(query: string): NeurologiaEntry[] {
  const q = query.toLowerCase();
  return neurologiaEnciclopedia.filter(
    (e) =>
      e.nombreEs.toLowerCase().includes(q) ||
      e.nombreEn.toLowerCase().includes(q) ||
      e.categoriaEs.toLowerCase().includes(q) ||
      e.categoriaEn.toLowerCase().includes(q) ||
      e.descripcionEs.toLowerCase().includes(q) ||
      e.descripcionEn.toLowerCase().includes(q)
  );
}

export function getNeurologiaById(id: string): NeurologiaEntry | undefined {
  return neurologiaEnciclopedia.find((e) => e.id === id);
}

export function getNeurologiaPorCategoria(cat: string): NeurologiaEntry[] {
  const c = cat.toLowerCase();
  return neurologiaEnciclopedia.filter(
    (e) =>
      e.categoriaEs.toLowerCase().includes(c) ||
      e.categoriaEn.toLowerCase().includes(c)
  );
}
